Psychedelic Commons
ExploreMethodsAbout
Share your data

Beidas Z

Canadian Centre for Psychedelic Science, Toronto, Ontario, Canada.

4 papers · 1 preprint

View
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

Beidas Z, Ragnhildstveit A, Blackman A +8

Europe PMC2026
View
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2026
View
PreprintPsilocybin

Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2025
View
ArticlePsilocybin

Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.

Syed OA, Petranker R, Fewster EC +5

Europe PMC2026
View
ArticlePsilocybin

Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.

Syed OA, Petranker R, Fewster EC +5

Europe PMC2026
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.